DocGo (DCGO) Expected to Announce Quarterly Earnings on Monday

DocGo (NASDAQ:DCGOGet Free Report) is expected to post its Q3 2025 results after the market closes on Monday, November 10th. Analysts expect DocGo to post earnings of ($0.09) per share and revenue of $69.9620 million for the quarter. DocGo has set its FY 2025 guidance at EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Monday, November 10, 2025 at 5:00 PM ET.

DocGo (NASDAQ:DCGOGet Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.05). The company had revenue of $80.42 million for the quarter, compared to the consensus estimate of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Stock Up 3.8%

Shares of DocGo stock opened at $1.09 on Monday. DocGo has a 52 week low of $1.04 and a 52 week high of $5.68. The business has a 50 day moving average price of $1.38 and a 200-day moving average price of $1.54. The company has a market cap of $106.61 million, a PE ratio of -5.74 and a beta of 0.93.

Institutional Investors Weigh In On DocGo

Several large investors have recently made changes to their positions in DCGO. Oxford Asset Management LLP boosted its holdings in shares of DocGo by 122.6% in the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock worth $146,000 after buying an additional 51,298 shares during the last quarter. Engineers Gate Manager LP purchased a new stake in DocGo during the second quarter worth about $52,000. Boothbay Fund Management LLC raised its position in DocGo by 512.6% in the second quarter. Boothbay Fund Management LLC now owns 185,690 shares of the company’s stock worth $292,000 after acquiring an additional 155,379 shares during the period. Bridgeway Capital Management LLC boosted its stake in DocGo by 19.3% in the second quarter. Bridgeway Capital Management LLC now owns 357,757 shares of the company’s stock valued at $562,000 after acquiring an additional 57,757 shares during the last quarter. Finally, Bank of America Corp DE grew its position in shares of DocGo by 89.7% during the 2nd quarter. Bank of America Corp DE now owns 313,563 shares of the company’s stock valued at $492,000 after acquiring an additional 148,281 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on DCGO. Zacks Research lowered DocGo from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 7th. Canaccord Genuity Group upped their target price on shares of DocGo from $1.45 to $1.60 and gave the stock a “hold” rating in a research note on Thursday, August 21st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of DocGo in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $3.24.

Read Our Latest Stock Analysis on DocGo

About DocGo

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Earnings History for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.